Henrietta Fore - Net Worth and Insider Trading

Henrietta Fore Net Worth

The estimated net worth of Henrietta Fore is at least $197,040 dollars as of 2024-09-20. Henrietta Fore is the Director of Theravance Biopharma Inc and owns about 24,000 shares of Theravance Biopharma Inc (TBPH) stock worth over $197,040. Details can be seen in Henrietta Fore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henrietta Fore has not made any transactions after 2017-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Henrietta Fore

Henrietta Fore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Henrietta Fore owns 4 companies in total, including Exxon Mobil Corp (XOM) , General Mills Inc (GIS) , and Theravance Biopharma Inc (TBPH) among others .

Click here to see the complete history of Henrietta Fore’s form 4 insider trades.

Insider Ownership Summary of Henrietta Fore

Ticker	Comapny	Transaction Date	Type of Owner
XOM	Exxon Mobil Corp	2012-02-29	director
GIS	General Mills Inc	2014-06-24	director
TBPH	Theravance Biopharma Inc	2017-08-11	director
		2010-10-20	director

Henrietta Fore Latest Holdings Summary

Henrietta Fore currently owns a total of 1 stock. Henrietta Fore owns 24,000 shares of Theravance Biopharma Inc (TBPH) as of August 11, 2017, with a value of $197,040.

Latest Holdings of Henrietta Fore

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TBPH	Theravance Biopharma Inc	2017-08-11	24,000	8.21	197,040

Holding Weightings of Henrietta Fore

Henrietta Fore Form 4 Trading Tracker

According to the SEC Form 4 filings, Henrietta Fore has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the acquisition of 6,000 shares on August 11, 2017, which cost Henrietta Fore around $143,940.

Insider Trading History of Henrietta Fore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Henrietta Fore Trading Performance

GuruFocus tracks the stock performance after each of Henrietta Fore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henrietta Fore is 19.38%. GuruFocus also compares Henrietta Fore's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henrietta Fore within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Henrietta Fore's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Henrietta Fore

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	33.86
Relative Return to S&P 500(%)	31.94

Henrietta Fore Ownership Network

Ownership Network List of Henrietta Fore

No Data

Ownership Network Relation of Henrietta Fore

Henrietta Fore Owned Company Details

What does Exxon Mobil Corp do?

Who are the key executives at Exxon Mobil Corp?

Henrietta Fore is the director of Exxon Mobil Corp. Other key executives at Exxon Mobil Corp include Vice President Darrin L Talley , Vice President and Controller Leonard M. Fox , and VP & Tax and Treasurer James R. Chapman .

Exxon Mobil Corp (XOM) Insider Trades Summary

Over the past 18 months, Henrietta Fore made no insider transaction in Exxon Mobil Corp (XOM). Other recent insider transactions involving Exxon Mobil Corp (XOM) include a net sale of 11,226 shares made by Darrin L Talley , a net sale of 1,177,000 shares made by Jeffrey W Ubben , and a net purchase of 18,310 shares made by Maria S. Dreyfus .

In summary, during the past 3 months, insiders sold 0 shares of Exxon Mobil Corp (XOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,088,226 shares of Exxon Mobil Corp (XOM) were sold and 918,310 shares were bought by its insiders, resulting in a net sale of 1,169,916 shares.

Exxon Mobil Corp (XOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Exxon Mobil Corp Insider Transactions

No Available Data

What does General Mills Inc do?

Who are the key executives at General Mills Inc?

Henrietta Fore is the director of General Mills Inc. Other key executives at General Mills Inc include Chief Innovation Officer Werner Lanette Shaffer , Senior Vice President Jonathon Nudi , and Executive Vice President Jeffrey L Harmening .

General Mills Inc (GIS) Insider Trades Summary

Over the past 18 months, Henrietta Fore made no insider transaction in General Mills Inc (GIS). Other recent insider transactions involving General Mills Inc (GIS) include a net sale of 18,030 shares made by Jonathon Nudi , a net sale of 60,056 shares made by Jeffrey L Harmening , and a net sale of 21,734 shares made by Bethany C. Quam .

In summary, during the past 3 months, insiders sold 0 shares of General Mills Inc (GIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 134,867 shares of General Mills Inc (GIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 134,867 shares.

General Mills Inc (GIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

General Mills Inc Insider Transactions

No Available Data

What does Theravance Biopharma Inc do?

Who are the key executives at Theravance Biopharma Inc?

Henrietta Fore is the director of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include 10 percent owner Eli Samaha , SVP & Comm & Medical Affairs Rhonda Farnum , and SVP & Development Richard A Graham .

Theravance Biopharma Inc (TBPH) Insider Trades Summary

Over the past 18 months, Henrietta Fore made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 19,057 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .

In summary, during the past 3 months, insiders sold 4,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 999,800 shares, with a net purchase of 995,800 shares. During the past 18 months, 29,286 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,469,638 shares.

Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Theravance Biopharma Inc Insider Transactions

No Available Data

What does Innoviva Inc do?

Who are the key executives at Innoviva Inc?

Henrietta Fore is the director of Innoviva Inc. Other key executives at Innoviva Inc include Chief Accounting Officer Marianne Zhen , Chief Financial Officer Stephen Basso , and Chief Medical Officer Margaret Koziel .

Innoviva Inc (INVA) Insider Trades Summary

Over the past 18 months, Henrietta Fore made no insider transaction in Innoviva Inc (INVA). Other recent insider transactions involving Innoviva Inc (INVA) include a net purchase of 723,000 shares made by Alexander J Denner , and a net sale of 10,994 shares made by Marianne Zhen .

In summary, during the past 3 months, insiders sold 0 shares of Innoviva Inc (INVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,994 shares of Innoviva Inc (INVA) were sold and 723,000 shares were bought by its insiders, resulting in a net purchase of 712,006 shares.

Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Innoviva Inc Insider Transactions

No Available Data

Henrietta Fore Mailing Address

Above is the net worth, insider trading, and ownership report for Henrietta Fore. You might contact Henrietta Fore via mailing address: Theravance, Inc., 901 Gateway Blvd., South San Francisco Ca 94080.

Discussions on Henrietta Fore

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.